Objectives: To investigate the effects of medium-and long-chain triacylglycerol (MLCT) on blood triglyceride (TG) in Chinese hypertriglyceridemic subjects. Methods: A double-blind controlled clinical trial was carried out, in which 112 subjects with hypertriglyceridemia were randomly divided into two dietary oil groups: (1) long-chain triacylglycerol (LCT) and (2) MLCT. All subjects were requested to ingest fixed energy and to continue their normal activity levels, and to consume LCT or MLCT oil at 25-30 g daily during the study period. Anthropometric measurements of body weight, body mass index (BMI), body fat, body fat percentage, waist and hip circumference (WC and HC), areas of subcutaneous and visceral fat by computed tomography scanning and blood biochemical markers were measured at the beginning and end of the study. Results: There were 50 and 51 subjects left in LCT and MLCT groups, respectively. There were no significant differences in daily intake of energy, protein, fat and carbohydrate, as well as the daily physical activity between the two groups during the study. After 8 weeks, MLCT group showed a significant decrease in body weight, BMI, WC, HC, ratio of WC and HC, body fat, body fat percentage and subcutaneous fat when compared with the initial values. The decrease in body weight, BMI, WC, body fat and subcutaneous and visceral fat was significantly greater in MLCT group than that in the LCT group. Furthermore, the serum concentrations of TG in MLCT group were significantly lower than those in the LCT group. Conclusions: Consumption of MLCT may reduce body weight, body fat and blood TG in hypertriglyceridemic subjects under an appropriate dietary regime.
Introduction
Hypertriglyceridemia is often observed in patients with obesity (Barness et al., 2007) , type 2 diabetes (Betteridge, 2000; Krentz, 2003) , atherosclerosis (Le and Walter, 2007) and metabolic syndrome (Kolovou et al., 2005; Ascaso et al., 2007) . Non-pharmacologic treatment of hypertriglyceridemia includes weight reduction, dietary modification and physical activity. Among dietary modifications, reducing intakes of overall energy and dietary fat, including saturated and trans fat intake, but increasing o-3 fatty acids, are often recommended (Yuan et al., 2007) . A wise choice of both the amount and the type of dietary fat is helpful for the management of hypertriglyceridemia.
Long-chain fatty acids, which contain more than 12 carbon atoms, are found abundantly in dietary fat, that is animal foods and many edible vegetable oils. Accordingly, medium-chain fatty acids (MCFAs) with 8-10 carbon atoms are found in coconut and palm kernel. Medium-chain triacylglycerol (MCT) has been used therapeutically since the 1950s in the treatment of fat malabsorption, cystic fibrosis and epilepsy because of its unique structural, absorption and metabolic characteristics (Calabrese et al., 1999) . MCT is easily hydrolyzed in the gastrointestinal tract and the fatty acids are transported directly to the liver through the portal venous system, in contrast to long-chain fatty acids, which are incorporated into chylomicrons for transport through the lymphatic system or peripheral circulation. MCFAs do not require carnitine to cross the double mitochondrial membrane of the hepatocyte, thus they quickly enter the mitochondria and undergo rapid b-oxidation to ketones (Bach and Babayan, 1982; Aoyama et al., 2007) , whereas most long-chain fatty acids are packaged into triglycerides (TG) in the hepatocyte (Calabrese et al., 1999) . So it is reasonable to presume that daily intake of MCT as a part of dietary fat will be considered to induce less accumulation of fat in human body and a lower TG level in blood. In the past few years, a greater interest has been focused on the effects of MCFAs or MCT on overweight and obesity. Many investigations have found that intake of MCFAs or MCT produced less body weight and body fat weight (Tsuji et al., 2001; Noguchi et al., 2002; St-Onge and Jones, 2003; Kasai et al., 2003b; Matsuo and Takeuchi, 2004) in both animals and humans. MCT is thought to be a potential agent in the prevention and treatment of obesity (St-Onge and Jones, 2002) .
MCT is difficult to be used as cooking oil and to substitute it for long-chain triacylglycerol (LCT) because of its lower smoke point. Recently, a new oil composed of medium-and long-chain triacylglycerol (MLCT) in the same glycerol molecule produced by transesterification technique (Ogawa et al., 2007) was permitted to use as cooking oil (by Japanese Ministry of Health, Labour and Welfare; Aoyama et al., 2007) . The purpose of this trial was to investigate whether the MLCT oil could reduce blood TG in hypertriglyceridemic humans undergoing a free living pattern.
Materials and methods

Subjects and protocol
One hundred and twelve human subjects with hypertriglyceridemia, in the range 1.7-4.5 mmol/l, and with body mass index (BMI) more than 22 kg/m 2 were enrolled in the study.
No diabetes, hypertension, hepatic and renal diseases had been diagnosed before in all these subjects. The study was carried out in accordance with the Helsinki Declaration and approved by the Ethnics Committee of Chinese Peoples' Liberation Army General Hospital. The study procedures were informed to all subjects in detail, and informed consents were signed by the volunteers before starting the study.
A randomized controlled and double-blind trial was used. Subjects were randomly assigned to the MLCT or LCT group and given random numbers by the providers of MLCT and LCT oils, who also encoded the oils with matching random numbers. Neither the subjects nor the researchers of this study know which subject was receiving which oils, until the study was over and the random code was broken. The subjects were requested to take in the dietary energy based on their individualized conditions and maintain a fixed daily physical activity during the 8-week study period. Diet and activity regimes were informed individually to all subjects by doctors or dietitians. The daily intakes of LCT and MLCT oils as cooking oil were recommended at 25-30 g measured by specified spoons, which were distributed to every subject. The oil amounts were about half of the daily totally ingested fat, which was limited to no more than 30% of total energy.
The subjects were instructed to record the type and time of daily physical activity and the contents and weight or volume of their daily meals in their dietary diaries for 3 days in a week (including a day of the weekend) at baseline and at weeks 2, 4, 6 and 8 of the study. The physical activity time was defined as the total time of the following daily physical activities: walking (4-5 km/h), housework doing, and child-caring and bicycle riding (o10 km/h). The diaries were collected to confirm whether the subjects followed the instructions or not, and if necessary, subjects were asked again on how to maintain their diet and activity regimes. Otherwise, the subjects were advised to drop out of the study. Daily intakes of energy, protein, fat and carbohydrate were calculated on the basis of the China Food Composition Tables published in 2002. Among subjects, one had traffic accident, one suffered from cerebral infarction, two were not willing to consume the specified oil and seven were unable to consume the oil for more than 3 consecutive days because three of them were out of town for their business trip and four were out for their vocation. Thus, these 11 subjects were excluded. Therefore, there were 101 subjects enrolled in the study. The characteristics of the subjects in the LCT and MLCT groups are described in Table 1 .
Oils
The test oils of LCT and MLCT were provided by The Nisshin OilliO Group Ltd (Tokyo, Japan). The fatty acids and TG compositions of LCT and MLCT oils are listed in MCFAs, that is C8:0 and C10:0 in MLCT oil, were 13% of total oil weight.
Anthropometric measurements
Anthropometric parameters were measured by investigators trained in advance. Subjects were asked to wear underwear when measured at the fasting condition. Body weight and height were measured to the nearest 0.1 kg and 0.1 cm, respectively. Waist circumference (WC) was measured at the umbilical level. Hip circumference (HC) was measured at the level of the greatest posterior protuberance. The ratio of WC and HC was calculated by dividing WC by HC. All measurements were taken at weeks 0 and 8 of the study.
Measurement of body fat and abdominal fat area by computed tomography
The measurements were carried out after overnight fasting at weeks 0 and 8 of the study. Body fat was measured using BCA-2A body composition analyst (Tongfang, Qinghua, Beijing, China). Computed tomography scanning at the umbilical level in all subjects was performed in Chinese Peoples' Liberation Army General Hospital using a Pro 16 CT (GE, Fairfield, Connecticut, USA). The areas of visceral and subcutaneous fat were obtained from the computed tomography images by the method reported earlier (Tokunaga et al., 1983) .
Blood sampling and biochemical measurement At weeks 0 and 8 of the study, blood samples were collected after an overnight fasting (at least longer than 12 h). The biochemical variables, including aspartate aminotransferase, alanine aminotransferase, blood glucose, total cholesterols, TGs, high-density lipoprotein cholesterol, low-density lipoprotein cholesterol, ApoA1, ApoB, ApoA2, Apo C2, ApoC3 and ApoE were measured using Hitachi 7600 automated analysis system. Blood adiponectin and leptin concentrations were determined by using commercial enzyme-linked immunosorbent assay kit of adiponectin (lot no. 7D79; Ostuka Pharmaceutical Co. Ltd, Tokyo, Japan) and leptin (lot no. 440011; B-Bridge International Inc., Mountain View, CA, USA), respectively, according to manual procedures provided with the kit. The blood sampling, anthropometric measuring and computed tomography scanning were performed on the same day.
Statistical analysis
Data are expressed as means±s.d. Differences in the values and changes in the values in LCT and MLCT groups were compared by a repeated-measures analysis of variance. When significant differences occurred, comparisons of means were performed by Student's t-test between the two groups, and between the initial and final means in the same group. All analyses were performed using SPSS 10.0 Version for Windows. The level of significant difference was set at Po0.05.
Results
Intake of energy, protein, fat, carbohydrate and physical activity There were no differences in daily consumption of total energy, protein, fat and carbohydrate between LCT and MLCT groups at baseline and at weeks 2, 4, 6 and 8 of the study. In addition, no significant differences in physical activity time between the two groups were observed at baseline and at weeks 2, 4, 6 and 8 (Table 3) .
Anthropometric measurements and body fat composition Body weight, BMI, WC and HC, ratio of WC and HC, body fat weight, body fat percentage, and areas of total abdominal fat and subcutaneous fat in subjects consuming MLCT oil were significantly lower at week 8 than at the initial week (Po0.05, Table 4 ). Body weight in subjects consuming LCT oil at week 8 was also decreased significantly (Po0.05, Table 4 ). No differences were found in BMI, WC, HC, ratio of WC and HC, body fat weight, body fat percentage and areas of subcutaneous fat in LCT group at week 8 when compared with the initial values (P40.05); however, the total abdominal fat and visceral fat areas were increased. At week 8, body weight, BMI, WC, body fat weight, body fat percentage, area of total abdominal fat and subcutaneous fat in MLCT were not different from those in LCT group (P40.05, Table 4 ), but the extent of decrease in these indicators was significantly greater in the MLCT group than in the LCT group (Po0.05, Table 4 ). At week 8 in the LCT group, blood TG, low-density lipoprotein cholesterol, ApoA1, ApoB, ApoA2 and ApoE increased significantly as compared with that at week 0 (Po0.05). Contrarily, a decrease of high-density lipoprotein cholesterol was found (Po0.05). Blood TG, ApoB, ApoA2, ApoC2 and ApoC3 in the MLCT group were much lower than those in the LCT group at week 8 (Po0.05). The magnitude of decrease in blood TG, low-density lipoprotein cholesterol, ApoB, ApoA2, ApoC2 and ApoC3 was greater in the MLCT group than in the LCT group (Po0.05, Table 5 ). There were no differences in aspartate aminotransferase, alanine aminotransferase, blood glucose and cholesterol between MLCT and LCT at initial and final studies, respectively (Po0.05, Table 5 ). There were no significant differences in blood adiponectin and leptin between MLCT and LCT groups at weeks 0 and 8 (P40.05, Table 6 ).
At the end of this study, there were 33.33 and 12% subjects with their blood TG falling below the diagnostic criteria (o1.7 mmol/l) in MLCT and LCT groups, respectively. The former was significantly much higher than the latter (x 2 ¼ 6.534, Po0.05).
Discussion
In this study, we reported that the consumption of oil with medium-and long-chain TG in hypertriglyceridemic subjects with BMI422 kg/m 2 at a fixed daily energy intake and physical activity could reduce anthropometric variables reflected by body weight, body fat weight, body fat percentage and subcutaneous fat. These results are consistent with many earlier reports ( There are lot of factors that might be responsible for the reductions of body weight and body fat. What readily occurred to us first is the lifestyle of subjects, mainly including daily total calorie intake and physical activity during study. Therefore, in this study, strict strategies on daily energy intake and physical activity were taken in every individual of both groups, and no significant differences in daily energy intake and physical activity time during the 8-week duration of experiment were observed, indicative of the good control of lifestyle of the individuals.
Reduction of body weight and body fat weight by consumption of MCT relative to LCT is attributed to increased energy expenditure and fat oxidation, respectively (St-Onge et al., 2003a, b; Ogawa et al., 2007) , but the energy expenditure and fat oxidation were to a lower extent in individuals of greater body weight compared with individuals of lower body weight (St-Onge and Jones, 2003) . This implies that subjects with greater BMI or body weight might not respond better to MCT. So, if subjects with greater BMI were enrolled in a trial, negative results might be expected.
A short term of consumption of MCT might also explain why no reduction of body weight and body fat weight were found in the earlier report (Hill et al., 1990 ) although higher calories from MCT were given. A recent study found that there were no significant differences between MCT and LCT diets for resting metabolic rate or mean postprandial energy expenditure on both days 1 and 7 after starting the 50.8 ± 12.5 53.8 ± 11.5 49.1 ± 11.9 51.5 ± 10.9 53.0 ± 11.2 Carbohydrate (g/d)
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experiment even though fat oxidation for the MCT-rich diet was significantly greater than that for the LCT-rich diet at different time points across the 5.5-h postprandial period (Alexandrou et al., 2007) . So, a longer term study is more reliable. Daily intake amount of MCT or MCFAs might also have influence on its effect. Greater intake amount of MCT does not seem to reduce body weight (Yost and Eckel, 1989; Hill et al., 1990) . On the other hand, recent researches found that smaller intake amount of MCT might be useful. Kasai et al. (2003b) reported that subjects consumed the test bread, made with 14 g (about 6% of total energy) of MLCT containing 1.7 g MCFAs, and had a significant reduction in body weight and body fat accumulation. Similar researches were often seen recently (Nosaka et al., 2003; Ogawa et al., 2007) . In our research, subjects were asked to consume 25-30 g MLCT oil daily, which contains about 13% MCFAs ( Table 2 ). The intake of MCFAs was about 3.25-3.9 g daily, which was about 1.65-1.95% of total calorie.
In a controlled double-blind study, Nosaka et al. (2002) found that serum TG levels of healthy subjects were not significantly different in the groups consuming 2200-2600 kcal daily for 4 weeks, of which 70-80 g was fat; the fat included 40 g of MCT or else 40 g of LCT.
A similar result of no difference in blood TG between MCT and LCT consumed for 12 weeks in humans was found later by the same author (Nosaka et al., 2003) . Some other researchers also observed the same results (Matsuo et al., 2001; Tsuji et al., 2001; Kasai et al., 2003b) . However, there were some reports contrary to the results mentioned above. MCT had reducing effects not only on postprandial TG but also on fasting TG levels in humans. In 25 male subjects with BMIX23 kg/m 2 , the intake of 10 g MCT induced lower postprandial TG as compared with the intake of 10 g LCT (Kasai et al., 2003a) . In another double-blind crossover study, the subjects ingested a liquid diet containing 20 g/d of MLCT or soybean oil in addition to their regular diets. The rate of variation of serum TG concentration was significantly lower after a consumption of the MLCT liquid diet for 3 weeks compared with the control soybean oil liquid diet .
In this research, we found that the consumption of MLCT oil for 8 weeks resulted in a significant reduction in fasting blood TG in hypertriglyceridemic subjects when compared with the consumption of LCT oil. The average magnitude of the decrease was 14.54% at the end of the investigation. Hypertriglyceridemia is diagnosed when fasting blood TG is more than 1.7 mmol/l in China, which is also suggested by the Adult Treatment Panel III of the national cholesterol education program (Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults, 2001). At the end point, much more subjects in the MLCT group than in the LCT group (33.33 vs 12.00%) fell below the diagnostic criteria in their blood TG levels. These results indicated that intake of MLCT oil could be one of effective ways to lower blood TG in some hypertriglyceridemic humans.
Blood TG levels at the fasting condition depend on two major determinants. One is hepatic production or secretion of TG into blood, and the other one is the peripheral removal of circulating TG from blood. The balance of two factors would decide and maintain the concentration of TG in blood. The drop in blood TG concentration after consecutive intake of MLCT oil might be possibly explained as (1) a reduction of hepatic secretion of TG in form of verylow-density lipoprotein into blood, (2) an increase in the clearance of TG from blood by lipoprotein lipase, an enzyme playing the major role in regulating the catabolism of TG-rich lipoproteins (Glisic et al., 2007) , or (3) a combination of the above, or (4) an increase in the removal of TG without a change in hepatic secretion of TG, or (5) both increases in hepatic production and peripheral clearance of TG, but the magnitude of the former is less than that of the latter. However, there were few reports indicative of the decreasing effect of MCT or MLCT intake on hepatic production of TG so far. Meanwhile, many investigations indicated that intake of MCT or MLCT oil promoted energy expenditure and fat oxidation in both liver and adipose tissue in animal and human studies (St-Onge et al., 2003a, b; Shinohara et al., 2006; Alexandrou et al., 2007; Roynette et al., 2008) . Collectively, oxidation of fatty acids stimulated by intake of MCFAs might be the most possible mechanism for lowering TG after the consumption of MLCT oil.
In addition to a decrease in blood TG, some lipoprotein and apolipoproteins, such as low-density lipoprotein cholesterol, ApoB, ApoA2, ApoC2 and ApoC3, were also improved much more in MLCT oil than in LCT oil in this study. This is a very interesting finding about the effects of MCT on apolipoproteins because no similar reports were found so far.
In conclusion, an adequate consumption of the oil with medium-and long-chain fatty acid may reduce body fat and concentration of blood TG and improve apolipoprotein metabolism in hypertriglyceridemic subjects under an appropriate dietary regime.
